GlassScriptPhysician profile
Ashish A Vyas
NPI 1528215811
$7,192.50
in general payments reported to CMS, 2019-2025
44 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $394 · 2021: $2,811 · 2022: $1,248 · 2023: $967 · 2024: $362 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924 · Consulting Fee: $150 · Education: $16.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.45 |
| Consulting Fee | $150.00 |
| Education | $16.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $974.84 | 2021-2025 | Ubrelvy, Qulipta |
| Amgen INC. | $854.60 | 2019-2024 | Uplizna, Aimovig |
| Pfizer INC. | $644.08 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $566.50 | 2021 | |
| Horizon Therapeutics Plc | $493.37 | 2021-2023 | Uplizna |
| Ucb, INC. | $448.27 | 2021-2023 | Briviact |
| Jazz Pharmaceuticals INC. | $290.79 | 2020-2023 | |
| Teva Pharmaceuticals USA, INC. | $276.23 | 2021-2023 | Austedo |
| Janssen Pharmaceuticals, INC | $242.40 | 2021-2022 | |
| Sk Life Science, INC. | $214.77 | 2020-2021 | |
| Biogen, INC. | $211.04 | 2019-2025 | Tysabri, Vumerity |
| Biohaven Pharmaceutical Holding Company LTD. | $174.09 | 2022 | |
| Genentech USA, INC. | $161.71 | 2019 | |
| Livanova USA, INC. | $161.43 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Emd Serono, INC. | $135.12 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.